Stellate ganglion blockade and/or bilateral cardiac sympathetic denervation effectively suppressed refractory ventricular tachycardia or ventricular fibrillation in a case series of 6 patients.
Case Report (n=6)
Does stellate ganglion blockade and/or bilateral cardiac sympathetic denervation suppress VT/VF in patients with refractory ventricular arrhythmias?
Stellate ganglion blockade and bilateral cardiac sympathetic denervation can effectively suppress refractory ventricular arrhythmias as an adjunct to conventional therapy.
Abstract Autonomic modulation is being increasingly employed as a strategy to treat ventricular arrhythmias refractory to beta‐blockers, antiarrhythmic drugs, and catheter‐based ablation procedures. We report 6 patients with refractory ventricular tachycardia (VT) or ventricular fibrillation (VF) treated with stellate ganglion blockade (SGB) and/or bilateral cardiac sympathetic denervation (CSD). Our case series emphasizes the concept that the cardiac sympathetic nerves are important targets in the management of ventricular arrhythmias. SGB and CSD can be effective in suppressing VT/VF and can be offered to patients with refractory ventricular arrhythmias as an adjunct to conventional therapy.
Cardona‐Guarache et al. (Thu,) conducted a case report in refractory ventricular tachycardia (VT) or ventricular fibrillation (VF) (n=6). Stellate ganglion blockade (SGB) and/or bilateral cardiac sympathetic denervation (CSD) was evaluated on suppression of VT/VF. Stellate ganglion blockade and/or bilateral cardiac sympathetic denervation effectively suppressed refractory ventricular tachycardia or ventricular fibrillation in a case series of 6 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: